Singapore, July 8 -- Restore Medical, a clinical-stage medtech startup based in Israel, developing transcatheter therapies for heart failure, has announced the successful closing of a$23 millionSeries B financing round.

The round is co-led by Pitango HealthTech and a global strategic healthcare partner, alongsidethe European Innovation Council (EIC) Fund, and continued support from existing investors including Peregrine Ventures, which has supported the company since its inception, and another strategic partner.

The round will fund the completion of Restore Medical's ongoing European feasibility study, which has demonstrated promising long-term safety and efficacy data, including meaningful improvements in ventricular reverse remodeling...